Thursday, March 21, 2019 9:23:19 AM
Oliveda International, Inc. Signs Auditor Engagement Letter to Begin Next Phase of Financial DisclosurePress Release | 03/21/2019
SANTA MONICA, CA, March 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Oliveda International, Inc. (OTC Pink: OLVI), a leading international natural cosmetics and wearable beauty and health technology innovator, today announced that it has signed an engagement letter to retain a PCAOB-registered independent public accounting firm to conduct an audit of its annual financial statements for 2017 and 2018, bringing OLVI a step closer to its stated goal of filing financial reports with the Securities and Exchange Commission. Audited annual financials will also meet a requirement of the OTCQB® Venture Market, in the event that OLVI decides to apply for an upgrade on the OTC Markets Group platform.
Oliveda International, Inc. expects to have its 2018 annual financial report and disclosure statement posted on the OTC Markets Group website within the next two weeks. In addition to the audit of the 2017 and 2018 annual financial statements, OLVI’s legal representatives are expected to begin preparing the company to file financials and information statements with the SEC.
“The next step in Oliveda’s International’s upgrade as a U.S. public company is to ensure the highest degree of transparency for our shareholders and all investors,” commented Chairman and CEO Thomas Lommel. “Qualifying as an SEC-reporting company, as well as for the OTCQB® Venture Market, will better position OLVI to initiate its expansion into new markets in North America and Asia. We very much look forward to our stockholders seeing the financial results for year-end 2018, which we expect to show continued revenue growth and very positive indicators for this year.”
OLVI’s quarterly and annual financial reports and disclosure statements can be found on the OTC Markets website at https://www.otcmarkets.com/stock/OLVI/disclosure.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM